The article and I agree that treatments have been improving. Certainly detection is improving results too, but that can't explain all the improvements we are seeing.

As far as your "systemic" comment, sure there is greater risk of cancer with aging due to the accumulation of mutations and dysregulation. But that's why customized treatments show so much promise. What I described is not a "conventional" treatment, I was talking about custom treatments designed for each cancer.